nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP3A4—Disulfiram—alcohol dependence	0.121	0.584	CbGbCtD
Trametinib—CYP3A4—Citalopram—alcohol dependence	0.0861	0.416	CbGbCtD
Trametinib—Dermatitis acneiform—Disulfiram—alcohol dependence	0.0229	0.0523	CcSEcCtD
Trametinib—Abdominal pain lower—Naltrexone—alcohol dependence	0.0115	0.0262	CcSEcCtD
Trametinib—Rash papular—Naltrexone—alcohol dependence	0.00978	0.0224	CcSEcCtD
Trametinib—MAP2K1—brainstem—alcohol dependence	0.00956	0.0568	CbGeAlD
Trametinib—MAP2K1—forebrain—alcohol dependence	0.00922	0.0548	CbGeAlD
Trametinib—MAP2K2—forebrain—alcohol dependence	0.00812	0.0482	CbGeAlD
Trametinib—MAP2K1—cardiovascular system—alcohol dependence	0.0078	0.0463	CbGeAlD
Trametinib—Cardiomyopathy—Acamprosate—alcohol dependence	0.00752	0.0172	CcSEcCtD
Trametinib—Skin papilloma—Citalopram—alcohol dependence	0.00708	0.0162	CcSEcCtD
Trametinib—MAP2K1—gonad—alcohol dependence	0.00708	0.042	CbGeAlD
Trametinib—MAP2K2—cardiovascular system—alcohol dependence	0.00687	0.0408	CbGeAlD
Trametinib—Dermatitis acneiform—Citalopram—alcohol dependence	0.00675	0.0155	CcSEcCtD
Trametinib—Night sweats—Naltrexone—alcohol dependence	0.00675	0.0154	CcSEcCtD
Trametinib—MAP2K2—pancreas—alcohol dependence	0.00667	0.0396	CbGeAlD
Trametinib—MAP2K1—digestive system—alcohol dependence	0.00647	0.0385	CbGeAlD
Trametinib—MAP2K2—gonad—alcohol dependence	0.00623	0.037	CbGeAlD
Trametinib—MAP2K1—blood—alcohol dependence	0.00617	0.0366	CbGeAlD
Trametinib—Haematochezia—Citalopram—alcohol dependence	0.00573	0.0131	CcSEcCtD
Trametinib—MAP2K2—digestive system—alcohol dependence	0.0057	0.0339	CbGeAlD
Trametinib—MAP2K2—blood—alcohol dependence	0.00543	0.0323	CbGeAlD
Trametinib—MAP2K2—midbrain—alcohol dependence	0.00536	0.0318	CbGeAlD
Trametinib—MAP2K1—endocrine gland—alcohol dependence	0.00535	0.0318	CbGeAlD
Trametinib—MAP2K1—testis—alcohol dependence	0.0051	0.0303	CbGeAlD
Trametinib—MAP2K1—nervous system—alcohol dependence	0.00501	0.0297	CbGeAlD
Trametinib—Eye haemorrhage—Citalopram—alcohol dependence	0.00492	0.0113	CcSEcCtD
Trametinib—Rash pustular—Acamprosate—alcohol dependence	0.00483	0.011	CcSEcCtD
Trametinib—MAP2K1—liver—alcohol dependence	0.00482	0.0286	CbGeAlD
Trametinib—MAP2K1—central nervous system—alcohol dependence	0.00482	0.0286	CbGeAlD
Trametinib—MAP2K1—cerebellum—alcohol dependence	0.00471	0.028	CbGeAlD
Trametinib—MAP2K2—endocrine gland—alcohol dependence	0.00471	0.028	CbGeAlD
Trametinib—Abdominal discomfort—Disulfiram—alcohol dependence	0.0047	0.0108	CcSEcCtD
Trametinib—MAP2K2—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—alcohol dependence	0.00457	0.0244	CbGpPWpGaD
Trametinib—Lymphopenia—Citalopram—alcohol dependence	0.00451	0.0103	CcSEcCtD
Trametinib—MAP2K2—testis—alcohol dependence	0.00449	0.0267	CbGeAlD
Trametinib—Gamma-glutamyltransferase increased—Naltrexone—alcohol dependence	0.00443	0.0101	CcSEcCtD
Trametinib—MAP2K2—nervous system—alcohol dependence	0.00441	0.0262	CbGeAlD
Trametinib—MAP2K1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—alcohol dependence	0.00428	0.0228	CbGpPWpGaD
Trametinib—Night sweats—Citalopram—alcohol dependence	0.00427	0.00978	CcSEcCtD
Trametinib—Rectal haemorrhage—Acamprosate—alcohol dependence	0.00426	0.00975	CcSEcCtD
Trametinib—MAP2K2—liver—alcohol dependence	0.00425	0.0252	CbGeAlD
Trametinib—MAP2K2—central nervous system—alcohol dependence	0.00424	0.0252	CbGeAlD
Trametinib—Hyperbilirubinaemia—Acamprosate—alcohol dependence	0.00423	0.00969	CcSEcCtD
Trametinib—MAP2K2—cerebellum—alcohol dependence	0.00415	0.0246	CbGeAlD
Trametinib—Gingival bleeding—Citalopram—alcohol dependence	0.00407	0.00931	CcSEcCtD
Trametinib—Creatinine increased—Acamprosate—alcohol dependence	0.00404	0.00925	CcSEcCtD
Trametinib—Cellulitis—Naltrexone—alcohol dependence	0.004	0.00916	CcSEcCtD
Trametinib—Oropharyngeal pain—Naltrexone—alcohol dependence	0.004	0.00916	CcSEcCtD
Trametinib—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00388	0.0207	CbGpPWpGaD
Trametinib—Phosphatase alkaline increased—Acamprosate—alcohol dependence	0.00385	0.00881	CcSEcCtD
Trametinib—MAP2K1—brain—alcohol dependence	0.00383	0.0227	CbGeAlD
Trametinib—Polyp—Citalopram—alcohol dependence	0.00379	0.00868	CcSEcCtD
Trametinib—Melaena—Acamprosate—alcohol dependence	0.00376	0.0086	CcSEcCtD
Trametinib—Folliculitis—Citalopram—alcohol dependence	0.00367	0.0084	CcSEcCtD
Trametinib—MAP2K1—Endothelin Pathways—NPY—alcohol dependence	0.0035	0.0187	CbGpPWpGaD
Trametinib—Rash maculo-papular—Acamprosate—alcohol dependence	0.0035	0.00801	CcSEcCtD
Trametinib—Mouth ulceration—Acamprosate—alcohol dependence	0.00348	0.00796	CcSEcCtD
Trametinib—CYP2C8—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00348	0.0185	CbGpPWpGaD
Trametinib—Cyst—Citalopram—alcohol dependence	0.00345	0.0079	CcSEcCtD
Trametinib—MAP2K2—brain—alcohol dependence	0.00337	0.02	CbGeAlD
Trametinib—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.0033	0.0176	CbGpPWpGaD
Trametinib—MAP2K2—Hypothetical Network for Drug Addiction—DRD4—alcohol dependence	0.00323	0.0172	CbGpPWpGaD
Trametinib—Blood alkaline phosphatase increased—Acamprosate—alcohol dependence	0.00321	0.00735	CcSEcCtD
Trametinib—Vaginal haemorrhage—Citalopram—alcohol dependence	0.00312	0.00713	CcSEcCtD
Trametinib—MAP2K2—Hypothetical Network for Drug Addiction—GRIN2B—alcohol dependence	0.00311	0.0166	CbGpPWpGaD
Trametinib—MAP2K2—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—alcohol dependence	0.00307	0.0164	CbGpPWpGaD
Trametinib—Renal failure acute—Acamprosate—alcohol dependence	0.00303	0.00693	CcSEcCtD
Trametinib—MAP2K1—Hypothetical Network for Drug Addiction—DRD4—alcohol dependence	0.00303	0.0161	CbGpPWpGaD
Trametinib—Rash erythematous—Citalopram—alcohol dependence	0.00301	0.0069	CcSEcCtD
Trametinib—MAP2K2—Hypothetical Network for Drug Addiction—DRD2—alcohol dependence	0.00301	0.0161	CbGpPWpGaD
Trametinib—Cardiac failure congestive—Naltrexone—alcohol dependence	0.00292	0.00667	CcSEcCtD
Trametinib—MAP2K1—Hypothetical Network for Drug Addiction—GRIN2B—alcohol dependence	0.00291	0.0155	CbGpPWpGaD
Trametinib—Rash pustular—Citalopram—alcohol dependence	0.00289	0.00662	CcSEcCtD
Trametinib—MAP2K1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—alcohol dependence	0.00287	0.0153	CbGpPWpGaD
Trametinib—MAP2K1—Hypothetical Network for Drug Addiction—DRD2—alcohol dependence	0.00282	0.015	CbGpPWpGaD
Trametinib—Hyponatraemia—Acamprosate—alcohol dependence	0.00281	0.00642	CcSEcCtD
Trametinib—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.0028	0.00642	CcSEcCtD
Trametinib—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.0028	0.0149	CbGpPWpGaD
Trametinib—Pain in extremity—Naltrexone—alcohol dependence	0.00264	0.00605	CcSEcCtD
Trametinib—Blood creatinine increased—Acamprosate—alcohol dependence	0.00262	0.00599	CcSEcCtD
Trametinib—Rhabdomyolysis—Citalopram—alcohol dependence	0.00261	0.00597	CcSEcCtD
Trametinib—Dry skin—Acamprosate—alcohol dependence	0.00256	0.00586	CcSEcCtD
Trametinib—Rectal haemorrhage—Citalopram—alcohol dependence	0.00255	0.00585	CcSEcCtD
Trametinib—Bone disorder—Citalopram—alcohol dependence	0.00255	0.00585	CcSEcCtD
Trametinib—Hyperbilirubinaemia—Citalopram—alcohol dependence	0.00254	0.00581	CcSEcCtD
Trametinib—Cellulitis—Citalopram—alcohol dependence	0.00254	0.00581	CcSEcCtD
Trametinib—Hypocalcaemia—Citalopram—alcohol dependence	0.00252	0.00577	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00252	0.00576	CcSEcCtD
Trametinib—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00247	0.0131	CbGpPWpGaD
Trametinib—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00246	0.00564	CcSEcCtD
Trametinib—Dehydration—Naltrexone—alcohol dependence	0.00246	0.00563	CcSEcCtD
Trametinib—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00246	0.0131	CbGpPWpGaD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00245	0.0131	CbGpPWpGaD
Trametinib—Abdominal pain upper—Naltrexone—alcohol dependence	0.00241	0.00553	CcSEcCtD
Trametinib—Fatigue—Disulfiram—alcohol dependence	0.0024	0.0055	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00238	0.00545	CcSEcCtD
Trametinib—Pancreatitis—Acamprosate—alcohol dependence	0.00237	0.00542	CcSEcCtD
Trametinib—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00234	0.0125	CbGpPWpGaD
Trametinib—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00233	0.00534	CcSEcCtD
Trametinib—Phosphatase alkaline increased—Citalopram—alcohol dependence	0.00231	0.00528	CcSEcCtD
Trametinib—Melaena—Citalopram—alcohol dependence	0.00225	0.00516	CcSEcCtD
Trametinib—Abdominal discomfort—Naltrexone—alcohol dependence	0.00219	0.00501	CcSEcCtD
Trametinib—Hyperglycaemia—Acamprosate—alcohol dependence	0.00218	0.00499	CcSEcCtD
Trametinib—CYP2C8—Xenobiotics—CYP2E1—alcohol dependence	0.00216	0.0115	CbGpPWpGaD
Trametinib—Dry eye—Citalopram—alcohol dependence	0.00213	0.00488	CcSEcCtD
Trametinib—Stomatitis—Acamprosate—alcohol dependence	0.0021	0.0048	CcSEcCtD
Trametinib—Rash maculo-papular—Citalopram—alcohol dependence	0.0021	0.0048	CcSEcCtD
Trametinib—Urinary tract infection—Acamprosate—alcohol dependence	0.00209	0.00479	CcSEcCtD
Trametinib—Neoplasm—Citalopram—alcohol dependence	0.00209	0.00477	CcSEcCtD
Trametinib—Mouth ulceration—Citalopram—alcohol dependence	0.00209	0.00477	CcSEcCtD
Trametinib—CYP2C8—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00207	0.0111	CbGpPWpGaD
Trametinib—Haematuria—Acamprosate—alcohol dependence	0.00205	0.0047	CcSEcCtD
Trametinib—Infestation—Naltrexone—alcohol dependence	0.00204	0.00466	CcSEcCtD
Trametinib—Infestation NOS—Naltrexone—alcohol dependence	0.00204	0.00466	CcSEcCtD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00203	0.0108	CbGpPWpGaD
Trametinib—Epistaxis—Acamprosate—alcohol dependence	0.00203	0.00465	CcSEcCtD
Trametinib—Asthenia—Disulfiram—alcohol dependence	0.002	0.00458	CcSEcCtD
Trametinib—Urinary tract infection—Naltrexone—alcohol dependence	0.00198	0.00453	CcSEcCtD
Trametinib—Haemoglobin—Acamprosate—alcohol dependence	0.00194	0.00445	CcSEcCtD
Trametinib—MAP2K1—Corticotropin-releasing hormone—CRHR1—alcohol dependence	0.00194	0.0103	CbGpPWpGaD
Trametinib—Haemorrhage—Acamprosate—alcohol dependence	0.00193	0.00442	CcSEcCtD
Trametinib—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.00193	0.00441	CcSEcCtD
Trametinib—Epistaxis—Naltrexone—alcohol dependence	0.00192	0.0044	CcSEcCtD
Trametinib—Oedema peripheral—Acamprosate—alcohol dependence	0.0019	0.00436	CcSEcCtD
Trametinib—CYP2C8—blood—alcohol dependence	0.00188	0.0112	CbGeAlD
Trametinib—MAP2K2—ErbB1 downstream signaling—WASF2—alcohol dependence	0.00187	0.00994	CbGpPWpGaD
Trametinib—Dizziness—Disulfiram—alcohol dependence	0.00184	0.00422	CcSEcCtD
Trametinib—MAP2K2—VEGFA-VEGFR2 Pathway—WASF2—alcohol dependence	0.00184	0.00979	CbGpPWpGaD
Trametinib—MAP2K2—TCR Signaling Pathway—OPRM1—alcohol dependence	0.00182	0.00971	CbGpPWpGaD
Trametinib—Renal failure acute—Citalopram—alcohol dependence	0.00181	0.00415	CcSEcCtD
Trametinib—Connective tissue disorder—Naltrexone—alcohol dependence	0.0018	0.00411	CcSEcCtD
Trametinib—MAP2K2—VEGFA-VEGFR2 Pathway—WASF1—alcohol dependence	0.00176	0.00939	CbGpPWpGaD
Trametinib—Rash—Disulfiram—alcohol dependence	0.00176	0.00402	CcSEcCtD
Trametinib—Headache—Disulfiram—alcohol dependence	0.00175	0.004	CcSEcCtD
Trametinib—MAP2K1—ErbB1 downstream signaling—WASF2—alcohol dependence	0.00175	0.0093	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by VEGF—WASF2—alcohol dependence	0.00173	0.00924	CbGpPWpGaD
Trametinib—Chills—Acamprosate—alcohol dependence	0.00173	0.00397	CcSEcCtD
Trametinib—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00173	0.00923	CbGpPWpGaD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00173	0.00921	CbGpPWpGaD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—WASF2—alcohol dependence	0.00172	0.00916	CbGpPWpGaD
Trametinib—Eye disorder—Naltrexone—alcohol dependence	0.00171	0.00391	CcSEcCtD
Trametinib—MAP2K1—TCR Signaling Pathway—OPRM1—alcohol dependence	0.0017	0.00908	CbGpPWpGaD
Trametinib—Cardiac disorder—Naltrexone—alcohol dependence	0.0017	0.00388	CcSEcCtD
Trametinib—Mental disorder—Acamprosate—alcohol dependence	0.00169	0.00388	CcSEcCtD
Trametinib—Malnutrition—Acamprosate—alcohol dependence	0.00168	0.00385	CcSEcCtD
Trametinib—Hyponatraemia—Citalopram—alcohol dependence	0.00168	0.00385	CcSEcCtD
Trametinib—Pain in extremity—Citalopram—alcohol dependence	0.00168	0.00383	CcSEcCtD
Trametinib—MAP2K2—Signaling by VEGF—WASF1—alcohol dependence	0.00166	0.00886	CbGpPWpGaD
Trametinib—Angiopathy—Naltrexone—alcohol dependence	0.00166	0.0038	CcSEcCtD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—WASF1—alcohol dependence	0.00165	0.00878	CbGpPWpGaD
Trametinib—Mediastinal disorder—Naltrexone—alcohol dependence	0.00165	0.00377	CcSEcCtD
Trametinib—Dysgeusia—Acamprosate—alcohol dependence	0.00165	0.00377	CcSEcCtD
Trametinib—Chills—Naltrexone—alcohol dependence	0.00164	0.00376	CcSEcCtD
Trametinib—CYP2C8—endocrine gland—alcohol dependence	0.00163	0.00969	CbGeAlD
Trametinib—Back pain—Acamprosate—alcohol dependence	0.00163	0.00372	CcSEcCtD
Trametinib—MAP2K1—Signaling by VEGF—WASF2—alcohol dependence	0.00162	0.00865	CbGpPWpGaD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—WASF2—alcohol dependence	0.00162	0.00865	CbGpPWpGaD
Trametinib—Muscle spasms—Acamprosate—alcohol dependence	0.00162	0.0037	CcSEcCtD
Trametinib—Mental disorder—Naltrexone—alcohol dependence	0.0016	0.00367	CcSEcCtD
Trametinib—Malnutrition—Naltrexone—alcohol dependence	0.00159	0.00364	CcSEcCtD
Trametinib—Dysgeusia—Naltrexone—alcohol dependence	0.00156	0.00357	CcSEcCtD
Trametinib—Dehydration—Citalopram—alcohol dependence	0.00156	0.00356	CcSEcCtD
Trametinib—MAP2K1—Signaling by VEGF—WASF1—alcohol dependence	0.00156	0.00829	CbGpPWpGaD
Trametinib—CYP2C8—testis—alcohol dependence	0.00156	0.00924	CbGeAlD
Trametinib—Anaemia—Acamprosate—alcohol dependence	0.00156	0.00356	CcSEcCtD
Trametinib—Back pain—Naltrexone—alcohol dependence	0.00154	0.00352	CcSEcCtD
Trametinib—Dry skin—Citalopram—alcohol dependence	0.00154	0.00351	CcSEcCtD
Trametinib—Muscle spasms—Naltrexone—alcohol dependence	0.00153	0.0035	CcSEcCtD
Trametinib—Abdominal pain upper—Citalopram—alcohol dependence	0.00153	0.0035	CcSEcCtD
Trametinib—Hypokalaemia—Citalopram—alcohol dependence	0.00152	0.00349	CcSEcCtD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—WASF2—alcohol dependence	0.00152	0.00809	CbGpPWpGaD
Trametinib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00151	0.00345	CcSEcCtD
Trametinib—Leukopenia—Acamprosate—alcohol dependence	0.00151	0.00345	CcSEcCtD
Trametinib—Vision blurred—Naltrexone—alcohol dependence	0.0015	0.00343	CcSEcCtD
Trametinib—MAP2K1—Corticotropin-releasing hormone—CRH—alcohol dependence	0.00149	0.00792	CbGpPWpGaD
Trametinib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00148	0.00338	CcSEcCtD
Trametinib—CYP2C8—liver—alcohol dependence	0.00147	0.00873	CbGeAlD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00147	0.00783	CbGpPWpGaD
Trametinib—Cough—Acamprosate—alcohol dependence	0.00147	0.00336	CcSEcCtD
Trametinib—Hypertension—Acamprosate—alcohol dependence	0.00145	0.00332	CcSEcCtD
Trametinib—Myalgia—Acamprosate—alcohol dependence	0.00143	0.00328	CcSEcCtD
Trametinib—Arthralgia—Acamprosate—alcohol dependence	0.00143	0.00328	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00142	0.00326	CcSEcCtD
Trametinib—Pancreatitis—Citalopram—alcohol dependence	0.00142	0.00325	CcSEcCtD
Trametinib—MAP2K2—Regulation of Actin Cytoskeleton—WASF2—alcohol dependence	0.00141	0.00751	CbGpPWpGaD
Trametinib—Dry mouth—Acamprosate—alcohol dependence	0.0014	0.00321	CcSEcCtD
Trametinib—Cough—Naltrexone—alcohol dependence	0.00139	0.00318	CcSEcCtD
Trametinib—Abdominal discomfort—Citalopram—alcohol dependence	0.00139	0.00318	CcSEcCtD
Trametinib—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00138	0.00738	CbGpPWpGaD
Trametinib—Hypertension—Naltrexone—alcohol dependence	0.00137	0.00315	CcSEcCtD
Trametinib—Infection—Acamprosate—alcohol dependence	0.00136	0.00312	CcSEcCtD
Trametinib—Arthralgia—Naltrexone—alcohol dependence	0.00136	0.0031	CcSEcCtD
Trametinib—Myalgia—Naltrexone—alcohol dependence	0.00136	0.0031	CcSEcCtD
Trametinib—MAP2K2—Regulation of Actin Cytoskeleton—WASF1—alcohol dependence	0.00135	0.0072	CbGpPWpGaD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00135	0.00308	CcSEcCtD
Trametinib—Thrombocytopenia—Acamprosate—alcohol dependence	0.00134	0.00308	CcSEcCtD
Trametinib—CYP3A4—digestive system—alcohol dependence	0.00134	0.00794	CbGeAlD
Trametinib—Skin disorder—Acamprosate—alcohol dependence	0.00133	0.00305	CcSEcCtD
Trametinib—Hyperhidrosis—Acamprosate—alcohol dependence	0.00133	0.00304	CcSEcCtD
Trametinib—MAP2K2—Regulation of Actin Cytoskeleton—CHRM2—alcohol dependence	0.00133	0.00706	CbGpPWpGaD
Trametinib—Dry mouth—Naltrexone—alcohol dependence	0.00133	0.00303	CcSEcCtD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—WASF2—alcohol dependence	0.00132	0.00703	CbGpPWpGaD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00132	0.00702	CbGpPWpGaD
Trametinib—Hyperglycaemia—Citalopram—alcohol dependence	0.00131	0.00299	CcSEcCtD
Trametinib—CYP2C8—Biological oxidations—ADH6—alcohol dependence	0.0013	0.00695	CbGpPWpGaD
Trametinib—Oedema—Naltrexone—alcohol dependence	0.0013	0.00297	CcSEcCtD
Trametinib—Infection—Naltrexone—alcohol dependence	0.00129	0.00295	CcSEcCtD
Trametinib—Infestation—Citalopram—alcohol dependence	0.00129	0.00295	CcSEcCtD
Trametinib—Infestation NOS—Citalopram—alcohol dependence	0.00129	0.00295	CcSEcCtD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00129	0.00687	CbGpPWpGaD
Trametinib—Nervous system disorder—Naltrexone—alcohol dependence	0.00127	0.00292	CcSEcCtD
Trametinib—CYP3A4—blood—alcohol dependence	0.00127	0.00756	CbGeAlD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—WASF1—alcohol dependence	0.00126	0.00674	CbGpPWpGaD
Trametinib—Skin disorder—Naltrexone—alcohol dependence	0.00126	0.00289	CcSEcCtD
Trametinib—Stomatitis—Citalopram—alcohol dependence	0.00126	0.00288	CcSEcCtD
Trametinib—Hyperhidrosis—Naltrexone—alcohol dependence	0.00126	0.00287	CcSEcCtD
Trametinib—Urinary tract infection—Citalopram—alcohol dependence	0.00125	0.00287	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00125	0.00286	CcSEcCtD
Trametinib—Insomnia—Acamprosate—alcohol dependence	0.00124	0.00284	CcSEcCtD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—CHRM2—alcohol dependence	0.00124	0.00661	CbGpPWpGaD
Trametinib—Haematuria—Citalopram—alcohol dependence	0.00123	0.00282	CcSEcCtD
Trametinib—Epistaxis—Citalopram—alcohol dependence	0.00122	0.00279	CcSEcCtD
Trametinib—Decreased appetite—Acamprosate—alcohol dependence	0.00119	0.00273	CcSEcCtD
Trametinib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00119	0.00271	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00118	0.00271	CcSEcCtD
Trametinib—Bradycardia—Citalopram—alcohol dependence	0.00118	0.0027	CcSEcCtD
Trametinib—Insomnia—Naltrexone—alcohol dependence	0.00118	0.00269	CcSEcCtD
Trametinib—Constipation—Acamprosate—alcohol dependence	0.00117	0.00269	CcSEcCtD
Trametinib—CYP2C8—brain—alcohol dependence	0.00117	0.00693	CbGeAlD
Trametinib—Haemoglobin—Citalopram—alcohol dependence	0.00116	0.00267	CcSEcCtD
Trametinib—Haemorrhage—Citalopram—alcohol dependence	0.00116	0.00265	CcSEcCtD
Trametinib—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.00116	0.00617	CbGpPWpGaD
Trametinib—Urinary tract disorder—Citalopram—alcohol dependence	0.00114	0.00262	CcSEcCtD
Trametinib—Oedema peripheral—Citalopram—alcohol dependence	0.00114	0.00261	CcSEcCtD
Trametinib—Connective tissue disorder—Citalopram—alcohol dependence	0.00114	0.00261	CcSEcCtD
Trametinib—Urethral disorder—Citalopram—alcohol dependence	0.00114	0.0026	CcSEcCtD
Trametinib—Decreased appetite—Naltrexone—alcohol dependence	0.00113	0.00258	CcSEcCtD
Trametinib—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00112	0.00257	CcSEcCtD
Trametinib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00112	0.00257	CcSEcCtD
Trametinib—Fatigue—Naltrexone—alcohol dependence	0.00112	0.00256	CcSEcCtD
Trametinib—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00111	0.00593	CbGpPWpGaD
Trametinib—Constipation—Naltrexone—alcohol dependence	0.00111	0.00254	CcSEcCtD
Trametinib—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00111	0.0059	CbGpPWpGaD
Trametinib—CYP3A4—endocrine gland—alcohol dependence	0.0011	0.00656	CbGeAlD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00109	0.00582	CbGpPWpGaD
Trametinib—Abdominal pain—Acamprosate—alcohol dependence	0.00109	0.00248	CcSEcCtD
Trametinib—Body temperature increased—Acamprosate—alcohol dependence	0.00109	0.00248	CcSEcCtD
Trametinib—Eye disorder—Citalopram—alcohol dependence	0.00108	0.00248	CcSEcCtD
Trametinib—CYP2C8—Biological oxidations—ADH1A—alcohol dependence	0.00108	0.00576	CbGpPWpGaD
Trametinib—Cardiac disorder—Citalopram—alcohol dependence	0.00108	0.00246	CcSEcCtD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00107	0.00569	CbGpPWpGaD
Trametinib—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00106	0.00243	CcSEcCtD
Trametinib—Angiopathy—Citalopram—alcohol dependence	0.00105	0.00241	CcSEcCtD
Trametinib—Mediastinal disorder—Citalopram—alcohol dependence	0.00104	0.00239	CcSEcCtD
Trametinib—Chills—Citalopram—alcohol dependence	0.00104	0.00238	CcSEcCtD
Trametinib—Arrhythmia—Citalopram—alcohol dependence	0.00104	0.00237	CcSEcCtD
Trametinib—CYP3A4—nervous system—alcohol dependence	0.00103	0.00614	CbGeAlD
Trametinib—Body temperature increased—Naltrexone—alcohol dependence	0.00103	0.00235	CcSEcCtD
Trametinib—Abdominal pain—Naltrexone—alcohol dependence	0.00103	0.00235	CcSEcCtD
Trametinib—Mental disorder—Citalopram—alcohol dependence	0.00102	0.00232	CcSEcCtD
Trametinib—Erythema—Citalopram—alcohol dependence	0.00101	0.00231	CcSEcCtD
Trametinib—Malnutrition—Citalopram—alcohol dependence	0.00101	0.00231	CcSEcCtD
Trametinib—CYP3A4—liver—alcohol dependence	0.000996	0.00592	CbGeAlD
Trametinib—CYP3A4—central nervous system—alcohol dependence	0.000995	0.00591	CbGeAlD
Trametinib—Dysgeusia—Citalopram—alcohol dependence	0.000988	0.00226	CcSEcCtD
Trametinib—Asthenia—Acamprosate—alcohol dependence	0.000985	0.00225	CcSEcCtD
Trametinib—Back pain—Citalopram—alcohol dependence	0.000976	0.00223	CcSEcCtD
Trametinib—Pruritus—Acamprosate—alcohol dependence	0.000972	0.00222	CcSEcCtD
Trametinib—Muscle spasms—Citalopram—alcohol dependence	0.00097	0.00222	CcSEcCtD
Trametinib—CYP2C8—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000951	0.00507	CbGpPWpGaD
Trametinib—Vision blurred—Citalopram—alcohol dependence	0.000951	0.00218	CcSEcCtD
Trametinib—Diarrhoea—Acamprosate—alcohol dependence	0.00094	0.00215	CcSEcCtD
Trametinib—MAP2K2—BDNF signaling pathway—GRIN2B—alcohol dependence	0.000934	0.00498	CbGpPWpGaD
Trametinib—Anaemia—Citalopram—alcohol dependence	0.000932	0.00213	CcSEcCtD
Trametinib—Asthenia—Naltrexone—alcohol dependence	0.000932	0.00213	CcSEcCtD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000928	0.00495	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—CNR1—alcohol dependence	0.000927	0.00494	CbGpPWpGaD
Trametinib—Pruritus—Naltrexone—alcohol dependence	0.000919	0.0021	CcSEcCtD
Trametinib—CYP2C8—Biological oxidations—ADH4—alcohol dependence	0.000918	0.00489	CbGpPWpGaD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000908	0.00484	CbGpPWpGaD
Trametinib—Dizziness—Acamprosate—alcohol dependence	0.000908	0.00208	CcSEcCtD
Trametinib—Leukopenia—Citalopram—alcohol dependence	0.000903	0.00207	CcSEcCtD
Trametinib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000896	0.00477	CbGpPWpGaD
Trametinib—Diarrhoea—Naltrexone—alcohol dependence	0.000889	0.00203	CcSEcCtD
Trametinib—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000884	0.00471	CbGpPWpGaD
Trametinib—Cough—Citalopram—alcohol dependence	0.00088	0.00201	CcSEcCtD
Trametinib—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000875	0.00466	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—GRIN2B—alcohol dependence	0.000874	0.00466	CbGpPWpGaD
Trametinib—Vomiting—Acamprosate—alcohol dependence	0.000873	0.002	CcSEcCtD
Trametinib—Hypertension—Citalopram—alcohol dependence	0.000871	0.00199	CcSEcCtD
Trametinib—MAP2K1—BDNF signaling pathway—CNR1—alcohol dependence	0.000867	0.00462	CbGpPWpGaD
Trametinib—Rash—Acamprosate—alcohol dependence	0.000866	0.00198	CcSEcCtD
Trametinib—Dermatitis—Acamprosate—alcohol dependence	0.000865	0.00198	CcSEcCtD
Trametinib—Headache—Acamprosate—alcohol dependence	0.00086	0.00197	CcSEcCtD
Trametinib—Dizziness—Naltrexone—alcohol dependence	0.000859	0.00197	CcSEcCtD
Trametinib—Arthralgia—Citalopram—alcohol dependence	0.000859	0.00197	CcSEcCtD
Trametinib—Myalgia—Citalopram—alcohol dependence	0.000859	0.00197	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000853	0.00195	CcSEcCtD
Trametinib—MAP2K1—FOXM1 transcription factor network—EP300—alcohol dependence	0.000841	0.00448	CbGpPWpGaD
Trametinib—Dry mouth—Citalopram—alcohol dependence	0.00084	0.00192	CcSEcCtD
Trametinib—Vomiting—Naltrexone—alcohol dependence	0.000826	0.00189	CcSEcCtD
Trametinib—MAP2K1—IFN-gamma pathway—EP300—alcohol dependence	0.000826	0.0044	CbGpPWpGaD
Trametinib—Oedema—Citalopram—alcohol dependence	0.000823	0.00188	CcSEcCtD
Trametinib—Rash—Naltrexone—alcohol dependence	0.000819	0.00187	CcSEcCtD
Trametinib—Dermatitis—Naltrexone—alcohol dependence	0.000818	0.00187	CcSEcCtD
Trametinib—Infection—Citalopram—alcohol dependence	0.000818	0.00187	CcSEcCtD
Trametinib—Nausea—Acamprosate—alcohol dependence	0.000816	0.00187	CcSEcCtD
Trametinib—Headache—Naltrexone—alcohol dependence	0.000814	0.00186	CcSEcCtD
Trametinib—Nervous system disorder—Citalopram—alcohol dependence	0.000807	0.00185	CcSEcCtD
Trametinib—Thrombocytopenia—Citalopram—alcohol dependence	0.000806	0.00184	CcSEcCtD
Trametinib—Skin disorder—Citalopram—alcohol dependence	0.0008	0.00183	CcSEcCtD
Trametinib—Hyperhidrosis—Citalopram—alcohol dependence	0.000796	0.00182	CcSEcCtD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000789	0.00421	CbGpPWpGaD
Trametinib—MAP2K1—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000782	0.00417	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—ADH7—alcohol dependence	0.000781	0.00416	CbGpPWpGaD
Trametinib—Nausea—Naltrexone—alcohol dependence	0.000772	0.00177	CcSEcCtD
Trametinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000757	0.00404	CbGpPWpGaD
Trametinib—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00075	0.00172	CcSEcCtD
Trametinib—CYP2C8—Biological oxidations—GGT2—alcohol dependence	0.000749	0.00399	CbGpPWpGaD
Trametinib—Insomnia—Citalopram—alcohol dependence	0.000745	0.0017	CcSEcCtD
Trametinib—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000744	0.00396	CbGpPWpGaD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000726	0.00387	CbGpPWpGaD
Trametinib—Decreased appetite—Citalopram—alcohol dependence	0.000716	0.00164	CcSEcCtD
Trametinib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000711	0.00163	CcSEcCtD
Trametinib—Fatigue—Citalopram—alcohol dependence	0.00071	0.00162	CcSEcCtD
Trametinib—Constipation—Citalopram—alcohol dependence	0.000704	0.00161	CcSEcCtD
Trametinib—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.0007	0.00373	CbGpPWpGaD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000692	0.00369	CbGpPWpGaD
Trametinib—MAP2K2—Kit receptor signaling pathway—EP300—alcohol dependence	0.000685	0.00365	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—ADH1B—alcohol dependence	0.000685	0.00365	CbGpPWpGaD
Trametinib—MAP2K1—Corticotropin-releasing hormone—POMC—alcohol dependence	0.000677	0.00361	CbGpPWpGaD
Trametinib—Gastrointestinal pain—Citalopram—alcohol dependence	0.000673	0.00154	CcSEcCtD
Trametinib—Body temperature increased—Citalopram—alcohol dependence	0.000651	0.00149	CcSEcCtD
Trametinib—Abdominal pain—Citalopram—alcohol dependence	0.000651	0.00149	CcSEcCtD
Trametinib—MAP2K1—Kit receptor signaling pathway—EP300—alcohol dependence	0.000641	0.00342	CbGpPWpGaD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000597	0.00318	CbGpPWpGaD
Trametinib—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000595	0.00317	CbGpPWpGaD
Trametinib—Asthenia—Citalopram—alcohol dependence	0.000591	0.00135	CcSEcCtD
Trametinib—Pruritus—Citalopram—alcohol dependence	0.000582	0.00133	CcSEcCtD
Trametinib—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.00058	0.00309	CbGpPWpGaD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000573	0.00306	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—MAOB—alcohol dependence	0.000567	0.00302	CbGpPWpGaD
Trametinib—Diarrhoea—Citalopram—alcohol dependence	0.000563	0.00129	CcSEcCtD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000552	0.00294	CbGpPWpGaD
Trametinib—Dizziness—Citalopram—alcohol dependence	0.000544	0.00125	CcSEcCtD
Trametinib—MAP2K2—Signaling Pathways in Glioblastoma—EP300—alcohol dependence	0.000527	0.00281	CbGpPWpGaD
Trametinib—Vomiting—Citalopram—alcohol dependence	0.000523	0.0012	CcSEcCtD
Trametinib—Rash—Citalopram—alcohol dependence	0.000519	0.00119	CcSEcCtD
Trametinib—Dermatitis—Citalopram—alcohol dependence	0.000519	0.00119	CcSEcCtD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000517	0.00275	CbGpPWpGaD
Trametinib—Headache—Citalopram—alcohol dependence	0.000516	0.00118	CcSEcCtD
Trametinib—MAP2K2—Signaling by GPCR—OPRK1—alcohol dependence	0.000508	0.00271	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000493	0.00263	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways in Glioblastoma—EP300—alcohol dependence	0.000493	0.00263	CbGpPWpGaD
Trametinib—Nausea—Citalopram—alcohol dependence	0.000489	0.00112	CcSEcCtD
Trametinib—MAP2K2—Axon guidance—GRIN2B—alcohol dependence	0.000488	0.0026	CbGpPWpGaD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000488	0.0026	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—ALDH2—alcohol dependence	0.000482	0.00257	CbGpPWpGaD
Trametinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000481	0.00256	CbGpPWpGaD
Trametinib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.00048	0.00256	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—WASF2—alcohol dependence	0.000477	0.00254	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—OPRK1—alcohol dependence	0.000475	0.00253	CbGpPWpGaD
Trametinib—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000474	0.00253	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.00046	0.00245	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—WASF1—alcohol dependence	0.000458	0.00244	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—GRIN2B—alcohol dependence	0.000457	0.00243	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—WASF2—alcohol dependence	0.000447	0.00238	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.00043	0.00229	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—WASF1—alcohol dependence	0.000428	0.00228	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000419	0.00223	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000402	0.00214	CbGpPWpGaD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00039	0.00208	CbGpPWpGaD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000389	0.00207	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—CYP2E1—alcohol dependence	0.000386	0.00206	CbGpPWpGaD
Trametinib—CYP2C8—Metapathway biotransformation—CYP2E1—alcohol dependence	0.00038	0.00203	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000368	0.00196	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—EP300—alcohol dependence	0.00036	0.00192	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—GGT1—alcohol dependence	0.000354	0.00189	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—GRIN2B—alcohol dependence	0.000348	0.00186	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—OPRD1—alcohol dependence	0.000341	0.00182	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—EP300—alcohol dependence	0.000337	0.00179	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PDYN—alcohol dependence	0.000327	0.00174	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—GRIN2B—alcohol dependence	0.000326	0.00174	CbGpPWpGaD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000321	0.00171	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—OPRD1—alcohol dependence	0.000319	0.0017	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—MAOA—alcohol dependence	0.000317	0.00169	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PDYN—alcohol dependence	0.000306	0.00163	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000305	0.00162	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CRHR1—alcohol dependence	0.000304	0.00162	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—OPRK1—alcohol dependence	0.0003	0.0016	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CHRM2—alcohol dependence	0.000286	0.00152	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CRHR1—alcohol dependence	0.000285	0.00152	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—OPRK1—alcohol dependence	0.000281	0.0015	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—WASF2—alcohol dependence	0.000278	0.00148	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CHRM2—alcohol dependence	0.000268	0.00143	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—WASF1—alcohol dependence	0.000267	0.00142	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—OPRM1—alcohol dependence	0.000263	0.0014	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—WASF2—alcohol dependence	0.00026	0.00139	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000259	0.00138	CbGpPWpGaD
Trametinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000258	0.00137	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.00025	0.00133	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—WASF1—alcohol dependence	0.000249	0.00133	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—OPRM1—alcohol dependence	0.000246	0.00131	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—NPY—alcohol dependence	0.000242	0.00129	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR1B—alcohol dependence	0.000233	0.00124	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CRH—alcohol dependence	0.000233	0.00124	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—NPY—alcohol dependence	0.000226	0.00121	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADH6—alcohol dependence	0.000223	0.00119	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CRH—alcohol dependence	0.000218	0.00116	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR1B—alcohol dependence	0.000218	0.00116	CbGpPWpGaD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000209	0.00111	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000207	0.0011	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—POMC—alcohol dependence	0.000207	0.0011	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000204	0.00109	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—DRD4—alcohol dependence	0.000204	0.00109	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—OPRD1—alcohol dependence	0.000202	0.00107	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CNR1—alcohol dependence	0.000195	0.00104	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PDYN—alcohol dependence	0.000193	0.00103	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—DRD4—alcohol dependence	0.000191	0.00102	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.00019	0.00101	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—DRD2—alcohol dependence	0.00019	0.00101	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR7—alcohol dependence	0.00019	0.00101	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—OPRD1—alcohol dependence	0.000189	0.00101	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADH1A—alcohol dependence	0.000185	0.000984	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CNR1—alcohol dependence	0.000182	0.00097	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PDYN—alcohol dependence	0.000181	0.000964	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CRHR1—alcohol dependence	0.00018	0.000958	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—WASF2—alcohol dependence	0.00018	0.000958	CbGpPWpGaD
Trametinib—MAP2K2—Disease—GOT2—alcohol dependence	0.000178	0.000948	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR7—alcohol dependence	0.000178	0.000947	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—DRD2—alcohol dependence	0.000178	0.000947	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—WASF1—alcohol dependence	0.000172	0.000918	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.00017	0.000908	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CHRM2—alcohol dependence	0.000169	0.000901	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—WASF2—alcohol dependence	0.000168	0.000896	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CRHR1—alcohol dependence	0.000168	0.000896	CbGpPWpGaD
Trametinib—MAP2K1—Disease—GOT2—alcohol dependence	0.000166	0.000887	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—WASF1—alcohol dependence	0.000161	0.000859	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AVP—alcohol dependence	0.00016	0.000852	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CHRM2—alcohol dependence	0.000158	0.000843	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADH4—alcohol dependence	0.000157	0.000837	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—OPRM1—alcohol dependence	0.000155	0.000827	CbGpPWpGaD
Trametinib—MAP2K2—Disease—GOT1—alcohol dependence	0.000154	0.000818	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AVP—alcohol dependence	0.00015	0.000797	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—OPRM1—alcohol dependence	0.000145	0.000774	CbGpPWpGaD
Trametinib—MAP2K1—Disease—GOT1—alcohol dependence	0.000144	0.000766	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NPY—alcohol dependence	0.000143	0.000761	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR1B—alcohol dependence	0.000138	0.000734	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CRH—alcohol dependence	0.000138	0.000734	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000136	0.000725	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NPY—alcohol dependence	0.000134	0.000712	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADH7—alcohol dependence	0.000134	0.000712	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR2A—alcohol dependence	0.000133	0.000709	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CRH—alcohol dependence	0.000129	0.000687	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR1B—alcohol dependence	0.000129	0.000687	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GGT2—alcohol dependence	0.000128	0.000682	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—EP300—alcohol dependence	0.000125	0.000667	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR2A—alcohol dependence	0.000124	0.000663	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD4—alcohol dependence	0.00012	0.000642	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADH6—alcohol dependence	0.00012	0.000638	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADH1B—alcohol dependence	0.000117	0.000624	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—EP300—alcohol dependence	0.000117	0.000624	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CNR1—alcohol dependence	0.000115	0.000613	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD4—alcohol dependence	0.000113	0.0006	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD2—alcohol dependence	0.000112	0.000598	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR7—alcohol dependence	0.000112	0.000598	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—POMC—alcohol dependence	0.000111	0.000591	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—EP300—alcohol dependence	0.000111	0.000589	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CNR1—alcohol dependence	0.000108	0.000573	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—POMC—alcohol dependence	0.000106	0.000566	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD2—alcohol dependence	0.000105	0.000559	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR7—alcohol dependence	0.000105	0.000559	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—EP300—alcohol dependence	0.000103	0.000551	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—POMC—alcohol dependence	9.94e-05	0.00053	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADH1A—alcohol dependence	9.92e-05	0.000528	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MAOB—alcohol dependence	9.7e-05	0.000517	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AVP—alcohol dependence	9.44e-05	0.000503	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AVP—alcohol dependence	8.83e-05	0.000471	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADH4—alcohol dependence	8.43e-05	0.000449	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALDH2—alcohol dependence	8.25e-05	0.00044	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	7.93e-05	0.000423	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2A—alcohol dependence	7.86e-05	0.000419	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2A—alcohol dependence	7.35e-05	0.000392	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADH7—alcohol dependence	7.17e-05	0.000382	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT2—alcohol dependence	7.02e-05	0.000374	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GGT2—alcohol dependence	6.87e-05	0.000366	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2E1—alcohol dependence	6.6e-05	0.000352	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EP300—alcohol dependence	6.44e-05	0.000343	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADH1B—alcohol dependence	6.29e-05	0.000335	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—POMC—alcohol dependence	6.28e-05	0.000334	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GGT1—alcohol dependence	6.06e-05	0.000323	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT1—alcohol dependence	6.06e-05	0.000323	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EP300—alcohol dependence	6.02e-05	0.000321	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EP300—alcohol dependence	5.94e-05	0.000317	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—POMC—alcohol dependence	5.87e-05	0.000313	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EP300—alcohol dependence	5.56e-05	0.000296	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MAOA—alcohol dependence	5.43e-05	0.000289	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	5.26e-05	0.00028	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MAOB—alcohol dependence	5.21e-05	0.000278	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALDH2—alcohol dependence	4.43e-05	0.000236	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EP300—alcohol dependence	4.16e-05	0.000222	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EP300—alcohol dependence	3.89e-05	0.000208	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT2—alcohol dependence	3.77e-05	0.000201	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	3.54e-05	0.000189	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—POMC—alcohol dependence	3.53e-05	0.000188	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT1—alcohol dependence	3.25e-05	0.000173	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GGT1—alcohol dependence	3.25e-05	0.000173	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MAOA—alcohol dependence	2.91e-05	0.000155	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—EP300—alcohol dependence	2.34e-05	0.000125	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—POMC—alcohol dependence	1.9e-05	0.000101	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—EP300—alcohol dependence	1.26e-05	6.7e-05	CbGpPWpGaD
